Bacteremia caused by Laribacter hongkongensis misidentified as Acinetobacter lwoffii: report of the first case in Korea

J Korean Med Sci. 2011 May;26(5):679-81. doi: 10.3346/jkms.2011.26.5.679. Epub 2011 Apr 21.

Abstract

Laribacter hongkongensis is an emerging pathogen in patients with community-acquired gastroenteritis and traveler's diarrhea. We herein report a case of L. hongkongensis infection in a 24-yr-old male with liver cirrhosis complicated by Wilson's disease. He was admitted to a hospital with only abdominal distension. On day 6 following admission, he complained of abdominal pain and his body temperature reached 38.6℃. The results of peritoneal fluid evaluation revealed a leukocyte count of 1,180/µL (polymorphonuclear leukocyte 74%). Growth on blood culture was identified as a gram-negative bacillus. The isolate was initially identified as Acinetobacter lwoffii by conventional identification methods in the clinical microbiology laboratory, but was later identified as L. hongkongensis on the basis of molecular identification. The patient was successfully treated with cefotaxime. To the best of our knowledge, this case is the first report of hospital-acquired L. hongkongensis bacteremia with neutrophilic ascites.

Keywords: Bacteremia; Laribacter hongkongensis; Neutrophilic Ascites.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter / isolation & purification
  • Acinetobacter Infections / complications
  • Acinetobacter Infections / diagnosis
  • Acinetobacter Infections / microbiology
  • Bacteremia / complications
  • Bacteremia / microbiology*
  • Cefotaxime / therapeutic use
  • Diagnosis, Differential
  • Gastroenteritis / complications
  • Gastroenteritis / diagnosis*
  • Gastroenteritis / microbiology*
  • Hepatolenticular Degeneration / complications
  • Hepatolenticular Degeneration / microbiology
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / microbiology
  • Male
  • Neisseriaceae / isolation & purification*
  • Phylogeny
  • Republic of Korea
  • Young Adult

Substances

  • Cefotaxime